Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001702626-21-000002

CEO & President acquired 11,627 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-24 Grant or award : show line 1 in the form +11,627 $1.29 $14,999 267,426 D
Loading xslF345X03/primary_doc.xml…